4.2 Article

Comparison between GenBody COVID-19 Rapid Antigen Kit and SARS-CoV-2 RT-PCR

Journal

CLINICAL LABORATORY
Volume 68, Issue 6, Pages 1291-1293

Publisher

CLIN LAB PUBL
DOI: 10.7754/Clin.Lab.2021.210717

Keywords

COVID-19; lateral flow assay; antigen; SARS-CoV-2; rapid antigen test

Ask authors/readers for more resources

The study found that the sensitivity of the GenBody COVID-19 antigen assay is inferior to the polymerase chain reaction test, but its relatively fast speed and high sensitivity at low cycle threshold values indicating high viral loads make it a simple and quick measure for detecting SARS-CoV-2 in individuals with high viral loads.
Background: SARS-CoV-2 rapid antigen test can supplement the nucleic acid amplification method. Methods: We calculated the sensitivity and specificity of the GenBody COVID-19 antigen assay using 155 nasopharyngeal specimens. Results: The sensitivity in samples with their respective cycle thresholds varied from 33.3% to 100%; the sensitivity of the antigen assay was inferior to that of the gold standard polymerase chain reaction test. Conclusions: Considering the relatively fast speed of the antigen test and high sensitivity at a low cycle threshold value indicating a high viral load, the GenBody COVID-19 antigen test can be an easy and quick measure for detecting SARS-CoV-2 in individuals with high viral loads.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available